chronic obesity treatment – The Milli Chronicle

Monday, January 5, 2026

Latest:

Maduro Faces U.S. Drug Charges in New York as Venezuela Adjusts to Power Shock
Russia Reassesses Global Strategy After Losing Venezuela Ally Amid U.S. Power Play
Iran’s Leadership Faces Mounting Pressure as Protests Intensify and U.S. Actions Abroad Raise Alarm
Switzerland Freezes Assets Linked to Venezuela’s Maduro as International Pressure Mounts
Bird Flu Outbreaks Raise Fresh Poultry and Public Health Concerns in Southern India

Factual Version of a Story

Featured News World

NewsDesk Milli Chronicle January 5, 2026 chronic obesity treatment, FDA approved weight loss pill, global pharma industry, healthcare accessibility, medical weight loss, metabolic health, needle free treatment, Novo Nordisk, obesity care, obesity treatment, oral weight loss medication, patient centered care, pharmaceutical innovation, self pay patients, semaglutide, telehealth pharmacy, US healthcare market, Wegovy pill, weight loss drug, weight management

Novo Nordisk Expands Weight-Loss Treatment Options with US Launch of Wegovy Oral Pill

The launch of Wegovy in pill form marks a major step in widening access to obesity treatment in the United